Cytokine levels of TGF-beta, IL-10, and sTNFalphaRII in type C chronic liver disease - PubMed (original) (raw)
Cytokine levels of TGF-beta, IL-10, and sTNFalphaRII in type C chronic liver disease
Vikas Verma et al. Dig Dis Sci. 2008 Aug.
Abstract
Cytokines play a key role in regulation of immunity and inflammation. The aim of the study was to detect serum levels of TGF-beta, IL-10, and sTNFalphaRII in patients with type C chronic liver disease (CLD) and to correlate these with biochemical and histopathological parameters used to assess the severity of the disease. Blood samples were aseptically collected from 90 CLD patients. Cytokine levels were also followed up in 39 chronic hepatitis cases. Levels of the cytokines in 90 CLD patients were significantly higher than in controls. In the follow up patients, 12 were non-responders and the serum levels of cytokines were still elevated after therapy whereas in 27 responders cytokine levels were significantly reduced after therapy and correlated well with biochemical and histopathological parameters. It is inferred that cytokine levels reflect the level of inflammation in chronic hepatitis C virus (HCV) infection and can be used as indirect markers to assess the severity of liver disease.
Similar articles
- The role of IDO, IL-10, and TGF-β in the HCV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Yang R, Gao N, Chang Q, Meng X, Wang W. Yang R, et al. J Med Virol. 2019 Feb;91(2):265-271. doi: 10.1002/jmv.25083. Epub 2018 Sep 24. J Med Virol. 2019. PMID: 29611873 - Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.
Kakumu S, Okumura A, Ishikawa T, Yano M, Enomoto A, Nishimura H, Yoshioka K, Yoshika Y. Kakumu S, et al. Clin Exp Immunol. 1997 Sep;109(3):458-63. doi: 10.1046/j.1365-2249.1997.4861382.x. Clin Exp Immunol. 1997. PMID: 9328122 Free PMC article. - [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
Delhem N, Cottrez F, Carpentier A, Miroux C, Moralès O, François V, Groux H, Auriault C, Pancré V. Delhem N, et al. Bull Cancer. 2008 Nov;95(11):1029-38. doi: 10.1684/bdc.2008.0752. Bull Cancer. 2008. PMID: 19036674 French. - The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals.
Debes JD, de Knegt RJ, Boonstra A. Debes JD, et al. Transplantation. 2017 May;101(5):910-915. doi: 10.1097/TP.0000000000001623. Transplantation. 2017. PMID: 28045877 Review. - Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
Li H, Huang MH, Jiang JD, Peng ZG. Li H, et al. World J Gastroenterol. 2018 Dec 21;24(47):5297-5311. doi: 10.3748/wjg.v24.i47.5297. World J Gastroenterol. 2018. PMID: 30598575 Free PMC article. Review.
Cited by
- Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress.
Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA, Leto TL. Boudreau HE, et al. J Virol. 2009 Dec;83(24):12934-46. doi: 10.1128/JVI.01059-09. Epub 2009 Oct 7. J Virol. 2009. PMID: 19812163 Free PMC article. - Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitis.
Bruno CM, Valenti M, Bertino G, Ardiri A, Amoroso A, Consolo M, Mazzarino CM, Neri S. Bruno CM, et al. Ann Saudi Med. 2011 Jul-Aug;31(4):360-4. doi: 10.4103/0256-4947.83215. Ann Saudi Med. 2011. PMID: 21808111 Free PMC article. - Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.
Babiker A, Hassan M, Muhammed S, Taylor G, Poonia B, Shah A, Bagchi S. Babiker A, et al. Clin Cardiol. 2020 Mar;43(3):222-234. doi: 10.1002/clc.23299. Epub 2019 Nov 30. Clin Cardiol. 2020. PMID: 31785111 Free PMC article. Review.
References
- Semin Liver Dis. 1995 Feb;15(1):70-81 - PubMed
- World J Gastroenterol. 2005 Nov 14;11(42):6624-30 - PubMed
- Turk J Gastroenterol. 2003 Mar;14(1):7-11 - PubMed
- J Hepatol. 1999 Feb;30(2):185-91 - PubMed
- Annu Rev Immunol. 2004;22:929-79 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical